Member Info for Aether

The share jump 30% on news that Polygon was still buying.

If there, is positive news about Activ-2 P3, could this rise to 60p?

Is this written in the protocol?

If this share went down to the 100s would it still be worth buying?

This has an estimated value of 220+ if the ACTIV-2 P3 trial is a success.

In the event of some positive news, for example, confirmation ACTIV-2 P3 recruiting, protocol amended to remove confounding factors, positive data from previous trials, how high could this go before ACTIVVE- P3 results?

Thank you for the reply, SD.

We need written confirmation about steroid use in this trial.

Synairgen needs to put this in the protocol or it could destroy this trial as well.

"Hopefully with Activ2 , things should be different .
There will be steroids involved , but only to the point where patients had been on them for other ailments .
In fact , to be on the trial , you'd assume they were instructed what they could or couldn't take that would jeopardize the results .
Obviously if they got too ill and required hospital care then they would , but other than that , the biggest worry with Activ 2 was that they may not be enough 'ill' patients ."

(1) Are we certain no steroids will be involved except those for other ailments?

(2) Assumptions are dangerous now. Have they been instructed, Yes or No?

(3) At the point they needed hospital care or otherwise need steroids I assume they'd be taken out of the study.

We need written confirmation about steroid use in this trial.

Synairgen needs to put this in the protocol or it could destroy this trial as well.

At what stage of treatment are steroids administered?

Does this overlap with the stage of treatment covered by the Activ-2 P3 trial?

This is important to find out.

There should be something included about this in the protocol :-O

So, the problem with steroids could happen again in Active-2 P3!?

This has an estimated value of 220+ if the ACTIV-2 P3 trial is a success.

Does Active-2 P3 have many of the problems of the SPRINTER trial?

If there are, is SNG aware of it and are they amending the rules to remedy this?

If there are, is SNG aware of it and are they amending the rules to remedy this?

Does Active-2 P3 have many of the problems of the SPRINTER trial?

Active-2 P3 has many of the problems of the SPRINTER trial.

Compared to previous days, it looks like low volumes.

When will it stop?

What would be a resonable bid pre-Activ 2 Phase 3 results?

Are we still in Activ-2 Phase 3?
If so, when is it beginning?

Thanks for taking the time to reply.

Why would the spread be so large compared to other brokers?

Is that still possible!

Why such a large spread? It wasn't that large earlier.

Hi,

On LSE the BID and ASK was 29.1 and 29.8.

On my brokers it is 29.1 and 30.54.

That's a difference of 2.7% compared to 5%.

That's a big difference.